BioXellS.p.A.

BioXell S.p.A. is a clinical-stage biopharmaceutical company that researches, discovers, and develops drug candidates to address unmet medical needs in urology, inflammation, pain, and other related conditions. The company focuses on the development of the monoclonal antibody BXL1H5 for the treatment of chronic pain.